POC Molecular Diagnostics Analyzer for Infectious Diseases Provides On-The-Spot Results

A new point of care (POC) molecular diagnostics analysis system based on Loop-Mediated Isothermal Amplification (LAMP) provides on-the-spot results and empowers physicians for early infectious disease diagnostics, thanks to its agility, speed and flexibility.

EDAN Instruments (Shenzhen, China) has unveiled its first molecular diagnostics analysis system, ClariLight CL30, which is designed to offer effective solutions for infectious disease diagnostics by reducing the window period. Unlike PCR-based methods (generally non-portable, laboratory setting, time-consuming), CL30 produces molecular results as quick as 15 minutes, while multi-parameters cartridges and the extraction-free procedure allow massive and rapid molecular tests feasible. Respiratory infection control is an issue of global concern, and pathogen identification is important for identifying and containing potential outbreaks. The analytes (SARS-CoV-2, Influenza A/B, Influenza A/B & SARS-CoV-2, Influenza A/B & RSV) on CL30 are tailored to the typical respiratory infections. EDAN had previously acquired the ClariLight molecular diagnostics POC platform of LGC.

"The advent of ClariLight CL30 scales up our product portfolio in diagnostics applications. As the fastest-growing segment of In-Vitro diagnostics, the development of molecular diagnostics is of strategic significance for EDAN. And we are well geared to grasp its prospective growth," said Alex You, Senior Director of EDAN Global Marketing & Strategic Operations. "CL30 renders accurate and effective results," Said Alex, "It helps to achieve patient-tailored interventions and therapeutics."

Related Links:
EDAN Instruments 

Visit expo >

Gold Member

Flocked Fiber Swabs

Puritan® Patented HydraFlock®

Automated Blood Typing System
IH-500 NEXT

New

ELISA System

ABSOL HS DUO

New

Silver Member

Rubella Infection ELISA

ReQuest RUBELLA IgM ELISA Kit